-
Behavioral and Social Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Optional)
(PA-19-226)
National Institute on Aging
Application Receipt Date(s): May 6, 2019, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
(PAR-19-222)
National Institute of Diabetes and Digestive and Kidney Diseases
National Human Genome Research Institute
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
(PAR-19-223)
National Institute on Drug Abuse
Application Receipt Date(s): October 21, 2019, October 19, 2020, October 19, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required)
(PAR-19-225)
National Institute of Environmental Health Sciences
Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Institutional Translational Research Training Program (T32)
(PAR-19-228)
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): May 29, 2019; June 29, 2020; May 26, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed)
(PAR-19-229)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): October 1, 2019; October 1, 2020; October 1, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Atopic Dermatitis Research Network Leadership Center (UM1) Clinical Trial Required
(RFA-AI-19-014)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): July 8, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional)
(RFA-AI-19-015)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): July 8, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
(RFA-DK-19-003)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): August 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18 Clinical Trial Not Allowed)
(RFA-FD-19-018)
Food and Drug Administration
Application Receipt Date(s): May 21, 2019, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Novel Approaches to Translational Evidence Generation to Advance Coordinated Registry Networks (CRNs) via Big Data Analytics Using Disparate Data Sources (U01 Clinical Trial Optional)
(RFA-FD-19-020)
Food and Drug Administration
Application Receipt Date(s): May 28, 2019, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
-
Research Project Grants in Pediatric Rehabilitation (R01 Clinical Trial Optional)
(RFA-HD-20-005)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): June 27, 2019 by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Using Data Analytics to Support Primary Care and Community Interventions to Improve Chronic Disease Prevention and Management and Population Health (R18)
(RFA-HS-19-002)
Agency for Healthcare Research and Quality
Application Receipt Date(s): May 29, 2019, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01)
(RFA-HS-19-003)
Agency for Healthcare Research and Quality
Application Receipt Date(s): May 29, 2019, by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.